Subscribe X
Back to Top



April 21, 2017 by Eric Sagonowsky | FiercePharma

GSK told to pay $3M for Chicago attorney’s suicide while on generic Paxil

GlaxoSmithKline came up short in efforts to convince a jury that it shouldn’t be liable for a Chicago lawyer’s 2010 suicide while he was on generic Paxil. On Thursday, jurors sided with the man’s widow, Wendy Dolin, and awarded a $3 million verdict against the drugmaker.

Throughout the trial, Dolin’s attorneys argued that Paxil’s label indicating suicide risks stop at age 24 is flawed, and that Glaxo held a responsibility to inform of the risks. Since generic drugmakers duplicate drug labels for their copycats, Glaxo was at fault in this case, they argued. And the jury agreed.

Read More

April 21, 2017 by Letters |

Prince Harry shows how NHS psychiatric services could move on

While experts are right to congratulate Prince Harry (Harry praised for telling of ‘chaos’ over Diana’s death, 18 April), and call for more spending on mental health, there is an elephant in the room. Mental health services are dominated by an outdated, simplistic medical model of distress that is rather at odds with the prince’s views. While he makes the obvious link between painful life events and mental health difficulties, our services are still telling distressed people that they have illnesses, like major depressive disorder, caused by chemical imbalances – an unsubstantiated drug company creation – and by inferior genes that make them more vulnerable than others to depression, anxiety, psychosis etc.

Read More

April 18, 2017 by Medscape

Strikingly High Death Rate in Early Psychosis a Wake-up Call

The death rate for young people who suffer a first episode of psychosis (FEP) is 24 times greater than that of their peers in the general population in the year following the episode, a new study suggests.

This finding is “striking,” lead investigator Michael Schoenbaum, PhD, of the National Institute of Mental Health in Bethesda, Maryland, told Medscape Medical News.

“We know that people with serious mental illness don’t live as long as other people. We expected there to be elevated mortality compared to a general population, but we did not expect necessarily to see excess mortality on the scale that we found. We were really blown away,” said Dr Schoenbaum.

The study also found “surprisingly” low rates of medical oversight and only modest involvement with psychosocial treatment providers after FEP.

Read More

April 14, 2017 by Eliza Galaher, QMHA

The Power of Story

#3 in the series An Affirming Flame: Veterans’ Journeys from Trauma to Healing

Because of the gravity of the war-related experiences many veterans face, one struggle for veterans living with PTSD is the willingness and/or ability to tell their own story. To tell the story means to face it again, and that can be terrifying. But from Washington, DC, to Seattle, Washington, to the Navajo Nation in the southwest United States, story-telling is proving to be a key means of healing from the very trauma the memories of which veterans have strived to keep at bay.

Read More

April 12, 2017 by Jay Watts |

Is mental illness real? You asked Google – here’s the answer

Every day millions of internet users ask Google life’s most difficult questions, big and small. Our writers answer some of the commonest queries

When people ask whether mental illness is real or not, my suspicion is that they really mean: does mental illness have a physical, material cause, in the same way as cancer or a broken leg? Can it be tested for, diagnosed and treated with the same certainty as a physical disease? Whatever the answer to that question, it should cast no doubts or aspersions on the very real suffering of people with mental health problems.

Read More

March 31, 2017 by Wendy N Nembhard et al | BMJ

Genetics effect outcomes for babies, mothers on SSRIs

Maternal and Infant Genetic Variants, Maternal Periconceptional Use of Selective Serotonin Reuptake Inhibitors, and Risk of Congenital Heart Defects in Offspring


Objective To evaluate whether the association between maternal periconceptional use of selective serotonin reuptake inhibitors (SSRIs) and increased risk of congenital heart defects in offspring is modified by maternal or infant genetic variants in folate, homocysteine, or transsulfuration pathways.

Read More

March 27, 2017 by Robert Whitaker |

The Door to a Revolution in Psychiatry Cracks Open

A MIA Report: Norway’s Health Ministry Orders Medication-Free Treatment

Åsgård psychiatric hospital in Tromsø, Norway is a rather tired-looking facility, its squat buildings mindful of institutional architecture from the Cold War era, and in terms of its geographic location, it could hardly be located further from the centers of western psychiatry. Tromsø lies 215 miles north of the Arctic Circle, with tourists coming during the winter months to catch a glimpse of the Northern Lights. Yet it is in this remote outpost, on a hospital floor that had been closed but was recently refurbished, that one can find a startling sign on the door to the ward: medikamentfritt behandlingstilbud.

The translation to English: medication free treatment. And this is an initiative that the Norwegian Ministry of Health ordered its four regional health authorities to create.

Read More

March 27, 2017 by Adam B. Hill, MD | New England Journal of Medicine

A Physician’s Perspective on Self-Care and Recovery

My name is Adam. I am a human being, a husband, a father, a pediatric palliative care physician, and an associate residency director. I have a history of depression and suicidal ideation and am a recovering alcoholic. Several years ago, I found myself sitting in a state park 45 minutes from my home, on a beautiful fall night under a canopy of ash trees, with a plan to never come home. For several months, I had been feeling abused, overworked, neglected, and underappreciated. I felt I had lost my identity. I had slipped into a deep depression and relied on going home at night and having a handful of drinks just to fall asleep. Yet mine is a story of recovery: I am a survivor of an ongoing national epidemic of neglect of physicians’ mental health.

Read More

March 23, 2017 by Nancy A. Melville | Medscape

Anxiety Therapy Better for Depression Than CBT?

Metacognitive therapy (MCT), a psychotherapeutic approach that targets persistent rumination and negative thought processes, has a large effect size when used to treat depression and may offer a viable alternative to mainstay cognitive-behavioral therapy (CBT), results from a new randomized control trial show.

Read More

March 22, 2017 by Liam Davenport | Medscape

Long-term Use of ADHD Meds: No Benefit, Impact on Growth

Children who are treated with stimulant medication for attention-deficit/hyperactivity disorder (ADHD) and who continue that treatment into adulthood may experience a suppression of height as adults without experiencing any ongoing reductions in symptoms, results of a long-term follow-up study indicate.

Read More

The contents of this Headlines page are provided for informational purposes. Any material, conclusions, or opinions presented in the linked articles are not officially endorsed by the Foundation for Excellence in Mental Health Care.